2.- HEMOSTASIA

11. Høgh AL, Nielsen KL. SAGE and LongSAGE. Methods Mol Biol 2008;387:3-24.
12. Miesbach W, Schenk J, Alesci S, Lindhoff-Last E. Comparison of the fibrinogen
Clauss assay and the fibrinogen PT derived method in patients with
dysfibrinogenemia. Thromb Res 2010; Dec;126(6):e428-33.
13. Carpenter SL, Mathew P. Alpha2-antiplasmin and its deficiency: fibrinolysis
out of balance. Haemophilia 2008; Nov;14(6):1250-4.
14. Favaloro EJ, Wong RC. Laboratory testing for the antiphospholipid syndrome:
making sense of antiphospholipid antibody assays. Clin Chem Lab Med 2011;
Mar;49(3):447-61.
15. Maurissen LF, Thomassen MC, Nicolaes GA, Dahlbäck B, Tans G, Rosing J, et
al. Re-evaluation of the role of the protein S-C4b binding protein complex in
activated protein C-catalyzed factor Va-inactivation. Blood 2008; Mar
15;111(6):3034-41.
16. Qian J, Lin J, Yao DM, Chen Q, Xiao GF, Ji RB, et al. Rapid detection of JAK2
V617F mutation using high-resolution melting analysis with LightScanner
platform. Clin Chim Acta 2010; Dec 14;411(23-24):2097-100.
17. Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson L, et al.
Harrison Principios de Medicina Interna. Mc Graw-Hill. 17 a edición
18. Castaman G, Rodeghiero F. Advances in the diagnosis and management of
type 1 von Willebrand disease. Expert Rev Hematol 2011; Feb;4(1):95-106.
19. Lapecorella M, Napolitano M, Bernardi F, Pinotti M, Sbrighi PS, Marchetti G, et
al. Effective hemostasis during minor surgery in a case of hereditary combined
deficiency of vitamin K-dependent clotting factors. Clin Appl Thromb Hemost
2010; Apr;16(2):221-3.
611